This company seems to have been delisted
Reason: Acquired by Amgen
Last recorded trade on: November 25, 2022
Source: https://www.amgen.com/newsroom/press-releases/2022/08/amgen-to-acquire-chemocentryx-for-$4-billion-in-cash
Reason: Acquired by Amgen
Last recorded trade on: November 25, 2022
Source: https://www.amgen.com/newsroom/press-releases/2022/08/amgen-to-acquire-chemocentryx-for-$4-billion-in-cash
ChemoCentryx
CCXI
HK$404.18
Share price
0.00%
Change (1 day)
32.78%
Change (1 year)
Categories
EPS for ChemoCentryx (CCXI)
EPS in 2022 (TTM): -HK$14.77
According to ChemoCentryx's latest financial reports the company's current EPS (TTM) is -HK$14.69. In 2021 the company made an earnings per share (EPS) of -HK$14.69 a decrease over its 2020 EPS that were of -HK$6.30.
EPS history for ChemoCentryx from 2012 to 2022
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2022 (TTM) | -HK$14.77 | 0.53% |
| 2021 | -HK$14.69 | 133.33% |
| 2020 | -HK$6.30 | -16.49% |
| 2019 | -HK$7.54 | 27.63% |
| 2018 | -HK$5.91 | -305.41% |
| 2017 | HK$2.88 | -142.53% |
| 2016 | -HK$6.76 | -19.44% |
| 2015 | -HK$8.40 | -0% |
| 2014 | -HK$8.40 | 13.68% |
| 2013 | -HK$7.39 | -16.67% |
| 2012 | -HK$8.86 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 | HK$143.51 | -1,076.72% | 🇺🇸 USA |
 | HK$28.61 | -294.74% | 🇺🇸 USA |
 | HK$27.22 | -285.22% | 🇬🇧 UK |
 | HK$30.86 | -310.05% | 🇺🇸 USA |
 | HK$109.50 | -845.25% | 🇺🇸 USA |
 | HK$110.00 | -848.68% | 🇺🇸 USA |
 | HK$14.46 | -198.41% | 🇺🇸 USA |
 | -HK$15.55 | 5.82% | 🇮🇱 Israel |
 | HK$14.16 | -196.39% | 🇺🇸 USA |